Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0326-2017

Drug recall · January 11, 2017

TEMAZEPAM CAPSULES USP recall

Why: Failed Stability Specifications

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

TEMAZEPAM CAPSULES USP, 7.5 mg, 100 count bottles, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-5891-21

Lots / codes

T248H15A, Exp. 08/17

Quantity
1200 bottles
Company
Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals, Huntsville, AL
Distribution
Nationwide
Initiated
December 22, 2016 · Voluntary: Firm initiated
Classified
January 3, 2017
Reported
January 11, 2017
Ended
September 18, 2017
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Temazepam

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.